Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Collegium Pharmaceutical Inc banner

Collegium Pharmaceutical Inc
NASDAQ:COLL

Watchlist Manager
Collegium Pharmaceutical Inc Logo
Collegium Pharmaceutical Inc
NASDAQ:COLL
Watchlist
Price: 46.2425 USD -2.87% Market Closed
Market Cap: $1.5B
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

COLL Price Targets Summary
Collegium Pharmaceutical Inc

Wall Street analysts forecast COLL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for COLL is 54.23 USD with a low forecast of 44.44 USD and a high forecast of 63 USD.

COLL Lowest Forecast
Wall Street Target
44.44 USD
-4% Downside
COLL Average Forecast
Wall Street Target
54.23 USD
17% Upside
COLL Highest Forecast
Wall Street Target
63 USD
36% Upside
Lowest
Price Target
44.44 USD
4% Downside
Average
Price Target
54.23 USD
17% Upside
Highest
Price Target
63 USD
36% Upside
Collegium Pharmaceutical Inc Competitors:
Price Targets
JEF
Jefferies Financial Group Inc
33% Upside
JEF
Jefferies Financial Group Inc
33% Upside

Revenue
Forecast

N/A
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

The compound annual growth rate of Collegium Pharmaceutical Inc's revenue for the next 4 years is 3%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

The compound annual growth rate of Collegium Pharmaceutical Inc's operating income for the next 3 years is 24%.

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-27%
Average Miss
N/A
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-27%
Average Miss

The compound annual growth rate of Collegium Pharmaceutical Inc's net income for the next 4 years is 21%.

What are analyst estimates?

See Also

Summary
COLL intrinsic value, competitors valuation, and company profile.
DCF Valuation
COLL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
COLL stock valuation using valuation multiples.
Wall Street Estimates
COLL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
COLL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is COLL's stock price target?
Price Target
54.23 USD

According to Wall Street analysts, the average 1-year price target for COLL is 54.23 USD with a low forecast of 44.44 USD and a high forecast of 63 USD.

What is Collegium Pharmaceutical Inc's Revenue forecast?
Projected CAGR
3%

The compound annual growth rate of Collegium Pharmaceutical Inc's revenue for the next 4 years is 3%.

What is Collegium Pharmaceutical Inc's Operating Income forecast?
Projected CAGR
24%

The compound annual growth rate of Collegium Pharmaceutical Inc's operating income for the next 3 years is 24%.

What is Collegium Pharmaceutical Inc's Net Income forecast?
Projected CAGR
21%

The compound annual growth rate of Collegium Pharmaceutical Inc's net income for the next 4 years is 21%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 316,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.